2.16.840.1.113883.10.21.4.13/hgraph

From HL7 IPS
Jump to: navigation, search
  1. Entry
     UV Medication Administration (2.16.840.1.113883.10.21.4.13)
    1. Entry
       UV Use Period (2.16.840.1.113883.10.21.9.1)
    2. Entry
       CDA Subject (Body) (2.16.840.1.113883.10.12.320)
    3. Entry
       UV Medication Information (simple) (2.16.840.1.113883.10.21.4.10)
      1. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    4. Entry
       UV Medication Information (detail) (2.16.840.1.113883.10.21.4.11)
      1. Entry
         UV Content (2.16.840.1.113883.10.21.4.17)
      2. Entry
         UV Generalized Medicine Class (2.16.840.1.113883.10.21.4.19)
      3. Entry
         UV Content (2.16.840.1.113883.10.21.4.17)
      4. Entry
         UV Generalized Medicine Class (2.16.840.1.113883.10.21.4.19)
      5. Entry
         UV Content (2.16.840.1.113883.10.21.4.17)
      6. Entry
         UV Generalized Medicine Class (2.16.840.1.113883.10.21.4.19)
      7. Entry
         UV Content (2.16.840.1.113883.10.21.4.17)
      8. Entry
         UV Generalized Medicine Class (2.16.840.1.113883.10.21.4.19)
      9. Entry
         UV Ingredient (2.16.840.1.113883.10.21.4.18)
      10. Entry
         UV Ingredient (2.16.840.1.113883.10.21.4.18)
      11. Entry
         UV Ingredient (2.16.840.1.113883.10.21.4.18)
      12. Entry
         UV Ingredient (2.16.840.1.113883.10.21.4.18)
      13. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    5. Entry
       CDA Author (Body) (2.16.840.1.113883.10.12.318)
      1. *
         CDA Person (2.16.840.1.113883.10.12.152)
      2. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      3. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    6. *
       CDA AssignedEntity (2.16.840.1.113883.10.12.153)
      1. *
         CDA Person (2.16.840.1.113883.10.12.152)
      2. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    7. Entry
       CDA RelatedEntity (2.16.840.1.113883.10.12.316)
      1. *
         CDA Person (2.16.840.1.113883.10.12.152)
    8. Entry
       CDA Participant (Body) (2.16.840.1.113883.10.12.321)
      1. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      2. Entry
         CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    9. Entry
       CDA Participant (Body) (2.16.840.1.113883.10.12.321)
      1. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      2. Entry
         CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    10. Entry
       CDA Participant (Body) (2.16.840.1.113883.10.12.321)
      1. Entry
         CDA Device (2.16.840.1.113883.10.12.315)
      2. Entry
         CDA PlayingEntity (2.16.840.1.113883.10.12.313)
    11. Entry
       UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    12. Entry
       UV Substitution Event Adminstration (2.16.840.1.113883.10.21.4.14)
    13. Entry
       UV Medication Order Reference (2.16.840.1.113883.10.21.4.8)
      1. Entry
         CDA Author (Body) (2.16.840.1.113883.10.12.318)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
    14. Entry
       UV Dispense Event Reference (2.16.840.1.113883.10.21.4.9)
    15. Entry
       UV ClinicalStatement Observation (2.16.840.1.113883.10.21.4.3)
      1. Entry
         CDA Subject (Body) (2.16.840.1.113883.10.12.320)
      2. Entry
         CDA Specimen (2.16.840.1.113883.10.12.322)
      3. Entry
         CDA Performer (Body) (2.16.840.1.113883.10.12.323)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      4. Entry
         CDA Author (Body) (2.16.840.1.113883.10.12.318)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        3. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      5. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      6. Entry
         CDA Participant (Body) (2.16.840.1.113883.10.12.321)
        1. Entry
           CDA Device (2.16.840.1.113883.10.12.315)
        2. Entry
           CDA PlayingEntity (2.16.840.1.113883.10.12.313)
      7. Entry
         CDA Reference (2.16.840.1.113883.10.12.324)
        1. Entry
           CDA ExternalAct (2.16.840.1.113883.10.12.325)
        2. Entry
           CDA ExternalObservation (2.16.840.1.113883.10.12.326)
        3. Entry
           CDA ExternalProcedure (2.16.840.1.113883.10.12.327)
        4. Entry
           CDA ExternalDocument (2.16.840.1.113883.10.12.328)
      8. Entry
         CDA Precondition (2.16.840.1.113883.10.12.329)
    16. Entry
       IPS Internal Reference (2.16.840.1.113883.10.22.4.31)
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.10.21.4.13/hgraph&oldid=9625"